Search
Navtemadlin
go.drugbank.com/drugs/DB15299InvestigationalNavtemadlin (AMG-232) is under investigation in clinical trial NCT03041688 (MDM2 Inhibitor AMG-232 and Decitabine in Treating Patients With Relapsed, Refractory, or Newly-Diagnosed Acute Myeloid Leukemia
Nanrilkefusp alfa
go.drugbank.com/drugs/DB17480InvestigationalNanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).
LYB014
go.drugbank.com/drugs/DB33993ExperimentalLYB014 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).
LYB017
go.drugbank.com/drugs/DB33994ExperimentalLYB017 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).
Famitinib
go.drugbank.com/drugs/DB11741InvestigationalFamitinib has been used in trials studying the treatment of Colorectal Cancer, Renal Cell Cancer, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, and Metastatic Renal Cell Cancer, among others
Cenicriviroc
go.drugbank.com/drugs/DB11758InvestigationalCenicriviroc has been used in trials studying the treatment of HIV-infection/AIDS, AIDS Dementia Complex, Nonalcoholic Steatohepatitis, Human Immunodeficiency Virus, and HIV-1-Associated Cognitive Motor
LYB027
go.drugbank.com/drugs/DB33995ExperimentalLYB027 is under investigation in clinical trial NCT07831226 (Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-59 Years).
Disoxaril
go.drugbank.com/drugs/DB08726ExperimentalThis compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring.
Danoprevir
go.drugbank.com/drugs/DB11779InvestigationalDanoprevir has been used in trials studying the treatment of Hepatitis C, Chronic.
Categories: Amino Acids, Peptides, and ProteinsMofezolac
go.drugbank.com/drugs/DB21153ExperimentalMofezolac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Mofezolac is a anti-inflammatory agent, ibufenac derivative. Mofezolac has a monoisotopic molecular weight of 339.11 Da.
Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal